Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 70
- Cultivation
Study on LED lighting provides important results for cannabis cultivation
The study looked at the effects of broad-spectrum white light on plant yield, morphology, development and quality in cannabis.
- Medical
US cannabis medicine technology to be available for European patients
The products will benefit European patients with rapid on-set effects within five to 15 minutes alongside improved absorption efficiency.
- Companies
European cannabis market to reach $4.2bn by 2027
A new report has projected the European medical cannabis market to reach $4.2bn by 2027, growing at a GACR of 17.1% from 2020.
- CBD Market
Cellular Goods sign agreement for launch of ingestible CBD products
The ingestible products will include a tincture, spray and capsules.
- CBD Market
Clever Leaves provides no-cost CBD to University of Missouri
Cleaver Leaves has announced it will be supporting The University of Missouri by providing CBD isolate at no cost.
- Companies
CanCoin: a FinTech solution for the European cannabis industry
The CanCoin is developing an entire ecosystem around the token in a bid to revolutionise the European cannabis market.
- CBD Market
Epidyolex receives approval for tuberous sclerosis seizures treatment
The approval applies in England, Wales and Scotland and follows the recent approval of the product in all 27 countries of the European Union.
- Companies
Cannabis testing market to reach $2.44bn by 2027
Cannabis drug manufacturers, consumables and advanced instruments are expected to dominate.
- Medical
Highlands complete one of “largest legal shipments” of cannabis to Europe
The cannabis was shipped from its outdoor cannabis cultivation facility in Lesotho, Africa.
- Companies
Grow Group hits 100 per cent crowdfunding target in one hour
Grow Group is the first British medical cannabis startup ever to crowdfund.
- CBD Market
Yooma completes dual-listing with start of trading on AQSE
The placing is the largest ever capital raise for a cannabis company on the Aquis exchange.
- CBD Market
Dragonfly to be first UK CBD brand available on Australian prescription
The move is the latest international business expansion step for the innovative brand.
